Join
Live feed
·
INSIDERFilingvia Quantisnow
PharmaCyte  Biotech Inc. logo

Director Abecassis Michael M was granted 37,500 shares and covered exercise/tax liability with 16,875 shares, increasing direct ownership by 1,237% to 22,292 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PMCB (PharmaCyte Biotech Inc.) and more on Quantisnow.